Related references
Note: Only part of the references are listed.Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
Taishiro Kishimoto et al.
SCHIZOPHRENIA BULLETIN (2014)
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review
Mark Taylor et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Long-acting injectable antipsychotics in early psychosis: a literature review
Robin Emsley et al.
EARLY INTERVENTION IN PSYCHIATRY (2013)
Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Is the PANSS used correctly? a systematic review
Michael Obermeier et al.
BMC PSYCHIATRY (2011)
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia
S. Heres et al.
EUROPEAN PSYCHIATRY (2011)
Evidence-based pharmacotherapy of schizophrenia
Stefan Leucht et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Global Mental Health 1 Poverty and mental disorders: breaking the cycle in low-income and middle-income countries
Crick Lund et al.
LANCET (2011)
Early identification of non-remission in first-episode psychosis in a two-year outcome study
E. Simonsen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan et al.
SCHIZOPHRENIA BULLETIN (2010)
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Eric Y. H. Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Family intervention for schizophrenia
Fiona Pharoah et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Clinical guideline recommendations for antipsychotic long-acting injections
John M. Kane et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan
Haider A. Naqvi et al.
PLOS ONE (2009)
Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)
Han Boter et al.
SCHIZOPHRENIA RESEARCH (2009)
Schizophrenia treatment in the developing world:: an interregional and multinational cost-effectiveness analysis
Dan Chisholm et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis - A preliminary study
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Long-acting formulations of atypical antipsychotics - Time to reconsider when to introduce depot antipsychotics
Pierre Chue et al.
CNS DRUGS (2007)
Olanzapine and haloperidol in first episode psychosis: Two-year data
A. I. Green et al.
SCHIZOPHRENIA RESEARCH (2006)
Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
N Schooler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia
SJ Keith et al.
PSYCHIATRIC SERVICES (2004)
A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis
P Oosthuizen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: A randomized double-blind trial
WF Gattaz et al.
PHARMACOPSYCHIATRY (2004)
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
JP Lacro et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Medication adherence of individuals with a first episode of psychosis
EL Coldham et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
JG Csernansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Determining the optimal dose of haloperidol in first-episode psychosis
P Oosthuizen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2001)
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia
M Gitlin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Systematic review of patient and nurse attitudes to depot antipsychotic medication
J Walburn et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Systematic meta-review of depot antipsychotic drugs for people with schizophrenia
CE Adams et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)